Glanbia PLC
GLB
Company Profile
Business description
Glanbia PLC is a ingredient and branded performance nutrition manufacturer company. Company offer an incredible breadth of expertise in nutrition. It works with food and beverage companies and sell the products across the globe . The company segments include Performance Nutrition (PN), Health & Nutrition (H&N) and Dairy Nutrition (DN). The company generates majority of the revenue from Performance Nutrition segment. Geographically, it has majority revenue from North America followed by Europe and Asia.
Contact
Ring Road, Glanbia House
KilkennyR95 E866
IRLT: +353 567772200
Sector
Consumer Defensive
Stock type
Defensive
Industry
Packaged Foods
Fiscal Year End
31 December 2026
Employees
5,800
Stocks News & Analysis
stocks
Eli Lilly receives FDA approval to add another oral GLP-1 to market
Wide moat Eli Lilly receives FDA approval for obesity pill.
stocks
Our top ASX picks in every sector
These companies are our favourite choices for investors wanting to boost Aussie equity exposure.
stocks
Which of the 3 giant AI IPOs should you buy?
OpenAI, Anthropic, and Databricks are expected to go public this year at massive valuations.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,774.90 | 124.80 | -1.40% |
| CAC 40 | 7,882.14 | 99.13 | -1.24% |
| DAX 40 | 22,929.11 | 369.78 | -1.59% |
| Dow JONES (US) | 46,565.74 | 224.23 | 0.48% |
| FTSE 100 | 10,305.02 | 59.77 | -0.58% |
| HKSE | 25,074.25 | 219.78 | -0.87% |
| NASDAQ | 21,840.95 | 250.32 | 1.16% |
| Nikkei 225 | 52,463.27 | 1,276.41 | -2.38% |
| NZX 50 Index | 12,902.15 | 76.28 | 0.59% |
| S&P 500 | 6,575.32 | 46.80 | 0.72% |
| S&P/ASX 200 | 8,579.50 | 105.50 | -1.21% |
| SSE Composite Index | 3,919.29 | 29.27 | -0.74% |